Skip to content

UNIPER: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

UNIPER

BE 0443.337.609
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€2,678
2024 · €6,044-€3,366
Equity
€220,933
2024 · €218,255+€2,678
Cash
€130,142
2024 · €122,614+€7,528
Balance sheet total
€277,611
2024 · €284,261-€6,650

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€8,074

    down €8,074 (-6.5%), from €124,119 to €116,046

  • Cash +€7,528

    up €7,528 (+6.1%), from €122,614 to €130,142

    mainly Stocks and contracts (+€8,074) and Trade debts (+€4,840)

  • Receivables within one year -€3,588

    down €3,588 (-10.7%), from €33,606 to €30,019

    of which Trade receivables: -€7,418

Equity and liabilities
  • Other debts -€9,043

    down €9,043 (-36.1%), from €25,019 to €15,976

  • Tax, wage and social debts -€5,384

    down €5,384 (-58.7%), from €9,174 to €3,790

    of which Remuneration and social security: -€4,126

  • Trade debts +€4,840

    up €4,840 (+15.7%), from €30,749 to €35,589

Income statement
  • Gross operating margin -€5,301

    down €5,301 (-45.0%), from €11,782 to €6,481

  • Depreciation -€1,009

    no longer reported in 2025 (was €1,009)

  • Taxes -€822

    down €822 (-39.8%), from €2,063 to €1,242

  • Other operating charges +€201

    up €201 (+30.3%), from €664 to €865

  • Financial charges -€160

    down €160 (-7.3%), from €2,189 to €2,028

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €6,044
Gross operating margin -€5,301
Depreciation +€1,009
Write-downs +€77
Other operating charges -€201
Financial income +€68
Financial charges +€160
Taxes +€822
Result 2025 €2,678

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€7,528
Investment €0
Financing €0
Cash 2024 €122,614
Net result for the year +€2,678
Stocks and contracts +€8,074
Receivables within one year +€3,588
Deferred charges and accrued income +€2,516
Trade debts +€4,840
Tax, wage and social debts -€5,384
Other debts -€9,043
Accrued charges and deferred income +€258
Cash 2025 €130,142
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €284,261 €277,611 -€6,650 -2.3%
Fixed assets 21/28 €1,025 €1,025 = 0.0%
Financial fixed assets 28 €1,025 €1,025 = 0.0%
Current assets 29/58 €283,236 €276,586 -€6,650 -2.3%
Stocks and contracts in progress 3 €124,119 €116,046 -€8,074 -6.5%
Stocks 30/36 €124,119 €116,046 -€8,074 -6.5%
Amounts receivable within one year 40/41 €33,606 €30,019 -€3,588 -10.7%
Trade receivables 40 €33,606 €26,188 -€7,418 -22.1%
Other amounts receivable 41 - €3,831 +€3,831
Cash at bank and in hand 54/58 €122,614 €130,142 +€7,528 +6.1%
Deferred charges and accrued income 490/1 €2,897 €380 -€2,516 -86.9%
Total equity and liabilities 10/49 €284,261 €277,611 -€6,650 -2.3%
Equity 10/15 €218,255 €220,933 +€2,678 +1.2%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €199,655 €202,333 +€2,678 +1.3%
Tax-exempt reserves 132 €6,819 €6,819 = 0.0%
Distributable reserves 133 €192,836 €195,514 +€2,678 +1.4%
Amounts payable 17/49 €66,006 €56,678 -€9,328 -14.1%
Amounts payable within one year 42/48 €64,943 €55,356 -€9,586 -14.8%
Trade debts 44 €30,749 €35,589 +€4,840 +15.7%
Suppliers 440/4 €30,749 €35,589 +€4,840 +15.7%
Taxes, remuneration and social security 45 €9,174 €3,790 -€5,384 -58.7%
Taxes 450/3 €3,302 €2,044 -€1,258 -38.1%
Remuneration and social security 454/9 €5,872 €1,746 -€4,126 -70.3%
Other amounts payable 47/48 €25,019 €15,976 -€9,043 -36.1%
Accrued charges and deferred income 492/3 €1,063 €1,322 +€258 +24.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,009 - -€1,009
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €77 - -€77
Other operating charges 640/8 €664 €865 +€201 +30.3%
Gross operating margin 9900 €11,782 €6,481 -€5,301 -45.0%
Operating profit (loss) 9901 €10,032 €5,616 -€4,416 -44.0%
Financial income 75/76B €264 €332 +€68 +25.6%
Recurring financial income 75 €264 €332 +€68 +25.6%
Financial charges 65/66B €2,189 €2,028 -€160 -7.3%
Recurring financial charges 65 €2,189 €2,028 -€160 -7.3%
Profit (loss) for the period before taxes 9903 €8,108 €3,920 -€4,188 -51.7%
Income taxes 67/77 €2,063 €1,242 -€822 -39.8%
Profit (loss) for the period 9904 €6,044 €2,678 -€3,366 -55.7%
Profit (loss) for the period to be appropriated 9905 €6,044 €2,678 -€3,366 -55.7%

Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.